Financial Network Wealth Advisors LLC
Position in BEAM — Beam Therapeutics Inc.
CIK 2012031
MURRAY, UT
Position in BEAM
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$6,864
+$2,098 QoQ
Shares Held
200
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#235
of 272 holders
Holding Since
Mar 2025
6 quarters on record
Common Shares in BEAM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Financial Network Wealth Advisors LLC holds $234,517 across 15 Biotechnology names. BEAM ranks #5 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
182 | $90,404 | |
| 2 | TECH |
BIO-TECHNE Corp
|
607 | $42,884 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
66 | $41,153 | |
| 4 | OCUL |
Ocular Therapeutix, Inc
|
2,638 | $25,905 | |
| 5 | BEAM |
Beam Therapeutics Inc.
This page
|
200 | $6,864 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
20 | $6,321 | |
| 7 | MRNA |
Moderna, Inc.
|
86 | $6,022 | |
| 8 | IMNM |
Immunome Inc.
|
179 | $3,793 |
All Filings in BEAM
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,864 | 200 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $4,766 | 200 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,544 | 200 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,854 | 200 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $3,402 | 200 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,906 | 200 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||